Atlas Trials

Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Clinical trial NCT00595985 · TERMINATED

Trial details

NCT number
NCT00595985
Sponsor
Fudan University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2007-07-01
Primary completion
2009-01-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.